Orexigen Therapeutics, Inc. 4
4 · Orexigen Therapeutics, Inc. · Filed Jun 2, 2017
Insider Transaction Report
Form 4
Lynch Thomas P.
EVP. General Counsel & Sec.
Transactions
- Award
Common Stock
2017-05-31$1.55/sh+1,704$2,641→ 1,704 total
Footnotes (1)
- [F1]Shares acquired under Issuer's 2013 Employee Stock Purchase Plan.